Songjiang Ma - 14 Aug 2024 Form 4 Insider Report for GYRE THERAPEUTICS, INC. (GYRE)

Role
President, Director
Signature
/s/ Ruoyu Chen, as attorney-in-fact for Songjiang Ma
Issuer symbol
GYRE
Transactions as of
14 Aug 2024
Net transactions value
$0
Form type
4
Filing time
16 Aug 2024, 21:01:34 UTC
Previous filing
22 Nov 2023
Next filing
19 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GYRE Stock Option (Right to Buy) Award $0 +26,000 $0.000000 26,000 14 Aug 2024 Common Stock 26,000 $9.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through August 14, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.